Theralase Technologies (TSE:TLT)

Theralase Technologies (TLT) Stock Price & Analysis


TLT Stock Chart & Stats

Day’s RangeC$0 - C$0
52-Week RangeC$0.16 - C$0.31
Previous CloseC$0.17
Average Volume (3M)115.60K
Market Cap
Enterprise ValueC$36.44M
Total Cash (Recent Filing)C$482.46K
Total Debt (Recent Filing)C$409.14K
Price to Earnings (P/E)-7.9
May 29, 2024
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding228,460,858
10 Day Avg. Volume170,343
30 Day Avg. Volume115,604
Standard Deviation0.19
Financial Highlights & Ratios
Price to Book (P/B)25.20
Price to Sales (P/S)113.09
Price to Cash Flow (P/CF)-17.30
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0



Options Prices

Currently, No data available

Ownership Overview

17.10% Insiders
<0.01% Other Institutional Investors
82.89% Public Companies and
Individual Investors


What was Theralase Technologies’s price range in the past 12 months?
Theralase Technologies lowest stock price was C$0.15 and its highest was C$0.31 in the past 12 months.
    What is Theralase Technologies’s market cap?
    Currently, no data Available
    When is Theralase Technologies’s upcoming earnings report date?
    Theralase Technologies’s upcoming earnings report date is May 29, 2024 which is in 37 days.
      How were Theralase Technologies’s earnings last quarter?
      Theralase Technologies released its earnings results on Mar 27, 2024. The company reported C$0 earnings per share for the quarter, the consensus estimate of C$0 by C$0.
        Is Theralase Technologies overvalued?
        According to Wall Street analysts Theralase Technologies’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Theralase Technologies pay dividends?
          Theralase Technologies does not currently pay dividends.
          What is Theralase Technologies’s EPS estimate?
          Theralase Technologies’s EPS estimate is C$0.
            How many shares outstanding does Theralase Technologies have?
            Theralase Technologies has 221,302,670 shares outstanding.
              What happened to Theralase Technologies’s price movement after its last earnings report?
              Theralase Technologies reported an EPS of C$0 in its last earnings report, expectations of C$0. Following the earnings report the stock price went down -11.111%.
                Which hedge fund is a major shareholder of Theralase Technologies?
                Currently, no hedge funds are holding shares in TSE:TLT

                Theralase Technologies Stock Smart Score

                Company Description

                Theralase Technologies

                Theralase Technologies Inc is focused on the design, development, manufacturing, and sale of patented laser technology platforms used in a wide range of bio-stimulative and bio-destructive clinical applications. The company operates in two divisions: The Photo Dynamic Therapy(PDT) division which is into research and development of Photo Dynamic Compounds for the treatment of cancer and Medical Laser Technology(MLT) division which manufactures products used by healthcare practitioners predominantly for the healing of pain. All of the company revenues were generated from MLT division. The company's products include TLC-1000 Controller, TLC-900 Multiple Probe, TLC-300 Triple Probe, and others.
                Similar Stocks
                Price & Change
                Ondine Biomedical, Inc.
                Popular Stocks
                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis